S2C7:Chemistry Manufacturing Controls

原文始发于微信公众号(化学音乐文化):S2C7:Chemistry Manufacturing Controls

S2C7:Chemistry   Manufacturing   Controls

Gary L. Fourman

S2C7:Chemistry   Manufacturing   Controls

B.S., Pharmacy, Purdue, 1978
MBA, Western Michigan, 1988
Upjohn/Pharmacia/Pfizer 1978 – 1989
Eli Lilly, 1989 – 2011
Guest and Limited Term Lecturer, Purdue, 2015 – 2019
Min Yue Pharos, 2019 – present

S2C7:Chemistry   Manufacturing   Controls
S2C7:Chemistry   Manufacturing   Controls

扫描左侧二维码,获取视频课;扫描右侧二维码,获取音频课

Chemistry Manufacturing Controls

FDA – Govt-Wide Qual. Assurance Program, Mfg. Review Branch

The Upjohn Co. (Pfizer) – 11 years

Principal for Starting Up a New Sterile Products GMP Facility

Troubleshooting and Restoring Distressed Mfg. Operations

Eli Lilly and Co. – 22 years

Product Development, Scale-up and Process Validation

DOE (Design of Experiments) and SPC (Statistical Process Control) Implementations

Regulatory Affairs – Lilly to FDA Communications Sytem

Implemented MES (Mfg. Execution Sys.) for All Aspects of Business and Mfg.

Purdue University Adj. Prof. Role – 4 years

Min Yue Pharos – 2019 present

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

(0)
打赏 为好文打赏 支持药时代 共创新未来! 为好文打赏 支持药时代 共创新未来!
上一篇 2020年2月18日 12:21
下一篇 2020年2月18日 12:29

相关推荐

公众号
公众号
分享本页
返回顶部
FDA批准首款NASH/MASH新药,中国药企如何分享这个百亿美元大蛋糕?点击观看直播